Sage Therapeutics Inc Cash Flow-to-Debt Ratio
Sage Therapeutics Inc cash flow-to-debt ratio. Sage Therapeutics Inc (SAGE) has a Cash Flow-to-Debt Ratio of -1.08x as of June 2025, meaning its operating cash flow of $-58.69 Million could theoretically repay -1% of its total liabilities ($54.19 Million) in one year. Check SAGE operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sage Therapeutics Inc (2012–2024)
Cash flow-to-debt ratio of Sage Therapeutics Inc from 2012 to 2024. Historical debt coverage capacity for Sage Therapeutics Inc across 13 annual periods. Check Sage Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Sage Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2012–2024)
Sage Therapeutics Inc cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for Sage Therapeutics Inc. For the full cash flow conversion analysis, see Sage Therapeutics Inc (SAGE) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.25x | $-267.19 Million | $82.13 Million | ▲ +50.2% |
| 2023 | -6.53x | $-540.59 Million | $82.75 Million | ▼ -47.5% |
| 2022 | -4.43x | $-460.04 Million | $103.85 Million | ▼ -12.8% |
| 2021 | -3.93x | $-378.18 Million | $96.26 Million | ▼ -151.4% |
| 2020 | 7.64x | $664.28 Million | $86.91 Million | ▲ +301.7% |
| 2019 | -3.79x | $-528.71 Million | $139.50 Million | ▼ -30.5% |
| 2018 | -2.90x | $-260.67 Million | $89.73 Million | ▲ +27.9% |
| 2017 | -4.03x | $-219.28 Million | $54.46 Million | ▼ -22.2% |
| 2016 | -3.30x | $-118.68 Million | $36.01 Million | ▲ +28.6% |
| 2015 | -4.61x | $-70.68 Million | $15.32 Million | ▼ -32.7% |
| 2014 | -3.48x | $-27.04 Million | $7.78 Million | ▼ -695.1% |
| 2013 | -0.44x | $-17.52 Million | $40.07 Million | ▲ +19.7% |
| 2012 | -0.54x | $-8.93 Million | $16.39 Million | — |